A phase II trial of surgical resection and adjuvant highdose hemithoracic radiation for malignant pleural mesothelioma Academic Article uri icon

Overview

MeSH Major

  • Hemibody Irradiation
  • Mesothelioma
  • Pleural Neoplasms

abstract

  • Hemithoracic radiation after complete surgical resection at a dose not previously reported is feasible. This approach dramatically reduces local recurrence and is associated with prolonged survival for early-stage tumors. Stage III disease has a high risk of early distant relapse and should be considered for trials of systemic therapy added to this regimen of resection and radiation.

publication date

  • October 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1067/mtc.2001.116560

PubMed ID

  • 11581615

Additional Document Info

start page

  • 788

end page

  • 95

volume

  • 122

number

  • 4